What is the current valuation of the US preimplantation genetic-testing market?

The market valuation was $450.0 Million in 2024. Read More

What is the projected market size for the US preimplantation genetic-testing market by 2035?

The market is projected to reach $950.0 Million by 2035. Read More

What is the expected CAGR for the US preimplantation genetic-testing market during the forecast period 2025 - 2035?

The expected CAGR is 7.03% during the forecast period. Read More

Which companies are considered key players in the US preimplantation genetic-testing market?

Key players include Illumina, Thermo Fisher Scientific, Fulgent Genetics, Natera, and CooperSurgical. Read More

What are the main application segments in the US preimplantation genetic-testing market?

Main application segments include Diagnostic Testing, Carrier Screening, and Embryo Selection. Read More

What is the valuation range for the Diagnostic Testing segment in the US preimplantation genetic-testing market?

The Diagnostic Testing segment ranges from $180.0 Million to $380.0 Million. Read More

Which technique segment is expected to have the highest valuation in the US preimplantation genetic-testing market?

Next Generation Sequencing is expected to have the highest valuation, ranging from $150.0 Million to $350.0 Million. Read More

What is the projected valuation for the Healthcare Providers client type in the US preimplantation genetic-testing market?

The projected valuation for Healthcare Providers is between $180.0 Million and $380.0 Million. Read More

What end-use segment is anticipated to dominate the US preimplantation genetic-testing market?

Fertility Clinics are anticipated to dominate, with a valuation range of $180.0 Million to $380.0 Million. Read More

How does the US preimplantation genetic-testing market compare to other segments in terms of growth?

The market appears to be on a growth trajectory, with a projected increase to $950.0 Million by 2035, indicating robust demand. Read More

US Preimplantation Genetic Testing Market

US Preimplantation Genetic Testing Market Research Report: Size, Share, Trend Analysis By Applications (Diagnostic Testing, Carrier Screening, Embryo Selection), By Technique (Polymerase Chain Reaction, Next Generation Sequencing, Fluorescence In Situ Hybridization, Single Nucleotide Polymorphism), By End Use (Fertility Clinics, Research Laboratories, Hospitals) and By Client Type (Individuals, Healthcare Providers, Healthcare Institutions) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.03%

2024 Market Size

$ 450 Million

2035 Market Size

$ 950 Million

Medical Device ● Updated August 2026 Report ID: MRFR/MED/13083-HCR | Pages: 100 | Author: Rahul Gotadki, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Application (USD Million)
  1. 4.1.1 Diagnostic Testing
  2. 4.1.2 Carrier Screening
  3. 4.1.3 Embryo Selection
2. 4.2 Chemicals and Materials, BY Technique (USD Million)
  1. 4.2.1 Polymerase Chain Reaction
  2. 4.2.2 Next Generation Sequencing
  3. 4.2.3 Fluorescence In Situ Hybridization
  4. 4.2.4 Single Nucleotide Polymorphism
3. 4.3 Chemicals and Materials, BY End Use (USD Million)
  1. 4.3.1 Fertility Clinics
  2. 4.3.2 Research Laboratories
  3. 4.3.3 Hospitals
4. 4.4 Chemicals and Materials, BY Client Type (USD Million)
  1. 4.4.1 Individuals
  2. 4.4.2 Healthcare Providers
  3. 4.4.3 Healthcare Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fulgent Genetics (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Natera (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 CooperSurgical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 PreventionGenetics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Genea (AU)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Reproductive Health Technologies (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY TECHNIQUE
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY CLIENT TYPE
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY CLIENT TYPE, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY CLIENT TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNIQUE, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY CLIENT TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Preimplantation Genetic Testing Market Segmentation

US Preimplantation Genetic Testing Market By Application (USD Million, 2025-2035)

Diagnostic Testing
Carrier Screening
Embryo Selection

US Preimplantation Genetic Testing Market By Technique (USD Million, 2025-2035)

Polymerase Chain Reaction
Next Generation Sequencing
Fluorescence In Situ Hybridization
Single Nucleotide Polymorphism

US Preimplantation Genetic Testing Market By End Use (USD Million, 2025-2035)

Fertility Clinics
Research Laboratories
Hospitals

US Preimplantation Genetic Testing Market By Client Type (USD Million, 2025-2035)

Individuals
US Preimplantation Genetic Testing Market Providers
US Preimplantation Genetic Testing Market Institutions

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”